Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function.

MLA

Sabatino, Joseph J., Jr, et al. “Multiple Sclerosis Therapies Differentially Affect SARS-CoV-2 Vaccine-Induced Antibody and T Cell Immunity and Function.” JCI Insight, vol. 7, no. 4, Feb. 2022. EBSCOhost, https://doi.org/10.1172/jci.insight.156978.

APA

Sabatino, J. J., Jr, Mittl, K., Rowles, W. M., McPolin, K., Rajan, J. V., Laurie, M. T., Zamecnik, C. R., Dandekar, R., Alvarenga, B. D., Loudermilk, R. P., Gerungan, C., Spencer, C. M., Sagan, S. A., Augusto, D. G., Alexander, J. R., DeRisi, J. L., Hollenbach, J. A., Wilson, M. R., Zamvil, S. S., & Bove, R. (2022). Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function. JCI Insight, 7(4). https://doi.org/10.1172/jci.insight.156978

Chicago

Sabatino, Joseph J, Jr, Kristen Mittl, William M Rowles, Kira McPolin, Jayant V Rajan, Matthew T Laurie, Colin R Zamecnik, et al. 2022. “Multiple Sclerosis Therapies Differentially Affect SARS-CoV-2 Vaccine-Induced Antibody and T Cell Immunity and Function.” JCI Insight 7 (4). doi:10.1172/jci.insight.156978.